30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Canada Biotechnology & Medical Research

Oncolytics Biotech Inc (ONC)

Track

Recent insider activity at Oncolytics Biotech Inc. shows a series of buy transactions by executives and officers, with the most recent occurring on March 12, 2026. These purchases indicate a positive sentiment from key personnel regarding the company's prospects.
Stock chart
Ticker: ONC Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kelly, Jared Ryan
Senior Officer of Issuer
1 purchase — total 4,848 USD
Buy 12 Mar 2026
Value US$4,001,854.36 | Price 39.78 | Shares 87,692
Buy 12 Mar 2026
Value US$884,446.64 | Price 415.78 | Shares 59,706
Buy 11 Mar 2026
Value US$10,300.00 | Price 1.03 | Shares 10,000
Buy 11 Mar 2026
Value US$10,300.00 | Price 1.03 | Shares 10,000
Buy 12 Feb 2026
Value US$33,864.00 | Price 0.85 | Shares 40,000
Buy 12 Feb 2026
Value US$25,338.00 | Price 0.84 | Shares 30,000
Buy 12 Feb 2026
Value US$10,104.00 | Price 0.84 | Shares 12,000
Buy 12 Feb 2026
Value US$24,839.00 | Price 0.84 | Shares 29,500
Buy 12 Feb 2026
Value US$10,033.16 | Price 0.83 | Shares 12,132
Buy 12 Feb 2026
Value US$8,298.00 | Price 0.83 | Shares 10,000
Buy 12 Feb 2026
Value US$21,240.00 | Price 0.85 | Shares 25,000
Buy 12 Feb 2026
Value US$30,291.78 | Price 0.86 | Shares 35,400
Buy 12 Feb 2026
Value US$10,104.00 | Price 0.84 | Shares 12,000
Buy 12 Feb 2026
Value US$24,839.00 | Price 0.84 | Shares 29,500
Buy 12 Feb 2026
Value US$30,291.78 | Price 0.86 | Shares 35,400
Buy 12 Feb 2026
Value US$10,033.16 | Price 0.83 | Shares 12,132
Buy 12 Feb 2026
Value US$33,864.00 | Price 0.85 | Shares 40,000
Buy 12 Feb 2026
Value US$25,338.00 | Price 0.84 | Shares 30,000
Buy 12 Feb 2026
Value US$8,298.00 | Price 0.83 | Shares 10,000
Buy 12 Feb 2026
Value US$21,240.00 | Price 0.85 | Shares 25,000
Buy 11 Feb 2026
Value US$49,590.00 | Price 0.83 | Shares 60,000
Buy 11 Feb 2026
Value US$4,681.60 | Price 0.84 | Shares 5,600
Buy 11 Feb 2026
Value US$25,417.52 | Price 0.86 | Shares 29,600
Buy 11 Feb 2026
Value US$25,417.52 | Price 0.86 | Shares 29,600
Buy 11 Feb 2026
Value US$4,681.60 | Price 0.84 | Shares 5,600
Buy 11 Feb 2026
Value US$49,590.00 | Price 0.83 | Shares 60,000
Buy 16 Jan 2026
Value US$103,770.00 | Price 1.04 | Shares 100,000
Buy 16 Jan 2026
Value US$103,770.00 | Price 1.04 | Shares 100,000
Buy 12 Aug 2025
Value US$20,280.50 | Price 0.86 | Shares 23,500
Buy 17 Jul 2025
Value US$19,050.00 | Price 1.27 | Shares 15,000
Buy 17 Jul 2025
Value CA$7,866.00 | Price 1.71 | Shares 4,600
Buy 16 Jul 2025
Value US$60,061.68 | Price 1.19 | Shares 50,400
Buy 15 Jul 2025
Value US$14,976.00 | Price 1.17 | Shares 12,800
Buy 15 Jul 2025
Value US$30,237.90 | Price 1.19 | Shares 25,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-12 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
87,692 -19.5%
39.78
US$4,001,854 		87,692 -19.5% 39.78 US$4,001,854
2026-03-13 2026-03-12 B Purchase
Kelly Jared

Chief Executive Officer

Executive Director
59,706 +17.9%
415.78
US$884,447 		59,706 +17.9% 415.78 US$884,447
2026-03-13 2026-03-11 B Purchase
Parsons, James Todd

Director of Issuer

Non-Executive Director
79,571 +49.4%
204.66
US$2,612,661 		79,571 +49.4% 204.66 US$2,612,661
2026-03-13 2026-03-11 B Purchase
Parsons James T.
Non-Executive Director
10,000 +31.4%
1.03
US$10,300 		10,000 +31.4% 1.03 US$10,300
2026-02-13 2026-02-12 B Purchase
0.6
Seizinger, Bernd Robert

Director of Issuer

Non-Executive Director
40,000 +7.6%
0.85
US$33,864 		40,000 +7.6% 0.85 US$33,864
2026-02-13 2026-02-12 B Purchase
Pisano, Wayne

Director of Issuer

Non-Executive Director
30,000 +11.6%
0.84
US$25,338 		30,000 +11.6% 0.84 US$25,338
2026-02-13 2026-02-12 B Purchase
Look, Kirk

Senior Officer of Issuer

Officer
12,000 +7.5%
0.84
US$10,104 		12,000 +7.5% 0.84 US$10,104
2026-02-13 2026-02-12 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
29,500 +37.1%
0.84
US$24,839 		29,500 +37.1% 0.84 US$24,839
2026-02-13 2026-02-12 B Purchase
Heineman, Thomas

Senior Officer of Issuer

Officer
12,132 +7.8%
0.83
US$10,033 		12,132 +7.8% 0.83 US$10,033
2026-02-13 2026-02-12 B Purchase
Hagerman, Allison

Senior Officer of Issuer

Officer
10,000 +14.3%
0.83
US$8,298 		10,000 +14.3% 0.83 US$8,298
2026-02-13 2026-02-12 B Purchase
Brown, Deborah

Director of Issuer

Non-Executive Director
25,000 +29.5%
0.85
US$21,240 		25,000 +29.5% 0.85 US$21,240
2026-02-13 2026-02-12 B Purchase
Andrews, Patricia

Director of Issuer

Non-Executive Director
35,400 +82.8%
0.86
US$30,292 		35,400 +82.8% 0.86 US$30,292
2026-02-13 2026-02-12 B Purchase
Look Kirk

Chief Financial Officer

Officer
12,000 +4.4%
0.84
US$10,104 		12,000 +4.4% 0.84 US$10,104
2026-02-13 2026-02-12 B Purchase
Kelly Jared

Chief Executive Officer

Executive Director
29,500 +37.1%
0.84
US$24,839 		29,500 +37.1% 0.84 US$24,839
2026-02-13 2026-02-12 B Purchase
0.5
Andrews Patricia S
Non-Executive Director
35,400 +82.8%
0.86
US$30,292 		35,400 +82.8% 0.86 US$30,292
2026-02-13 2026-02-12 B Purchase
Heineman Thomas Charles

Chief Medical Officer

Officer
12,132 +4.5%
0.83
US$10,033 		12,132 +4.5% 0.83 US$10,033
2026-02-13 2026-02-12 B Purchase
2.9
Seizinger Bernd R.
Non-Executive Director
40,000 +7.6%
0.85
US$33,864 		40,000 +7.6% 0.85 US$33,864
2026-02-13 2026-02-12 B Purchase
2.9
Pisano Wayne
Non-Executive Director
30,000 +6.5%
0.84
US$25,338 		30,000 +6.5% 0.84 US$25,338
2026-02-13 2026-02-12 B Purchase
Hagerman Allison

VP, Product Development

Officer
10,000 +9.5%
0.83
US$8,298 		10,000 +9.5% 0.83 US$8,298
2026-02-13 2026-02-12 B Purchase
Brown Deborah Margaret
Non-Executive Director
25,000 +29.5%
0.85
US$21,240 		25,000 +29.5% 0.85 US$21,240
2026-02-13 2026-02-11 B Purchase
0.6
Seizinger, Bernd Robert

Director of Issuer

Non-Executive Director
60,000 +12.8%
0.83
US$49,590 		60,000 +12.8% 0.83 US$49,590
2026-02-13 2026-02-11 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
5,600 +7.6%
0.84
US$4,682 		5,600 +7.6% 0.84 US$4,682
2026-02-13 2026-02-11 B Purchase
Aromando, Andrew P.

Senior Officer of Issuer

Officer
29,600 +116.1%
0.86
US$25,418 		29,600 +116.1% 0.86 US$25,418
2026-02-13 2026-02-11 B Purchase
Aromando Andrew

Chief Business Officer

Officer
29,600 +116.1%
0.86
US$25,418 		29,600 +116.1% 0.86 US$25,418
2026-02-13 2026-02-11 B Purchase
Kelly Jared

Chief Executive Officer

Executive Director
5,600 +7.6%
0.84
US$4,682 		5,600 +7.6% 0.84 US$4,682
2026-02-13 2026-02-11 B Purchase
2.9
Seizinger Bernd R.
Non-Executive Director
60,000 +12.8%
0.83
US$49,590 		60,000 +12.8% 0.83 US$49,590
2026-01-20 2026-01-16 B Purchase
0.6
Seizinger, Bernd Robert

Director of Issuer

Non-Executive Director
100,000 +27.2%
1.04
US$103,770 		100,000 +27.2% 1.04 US$103,770
2026-01-20 2026-01-16 B Purchase
2.9
Seizinger Bernd R.
Non-Executive Director
100,000 +27.2%
1.04
US$103,770 		100,000 +27.2% 1.04 US$103,770
2025-08-12 2025-08-12 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
23,500 +46.6%
0.86
US$20,280 		23,500 +46.6% 0.86 US$20,280
2025-07-18 2025-07-17 B Purchase
Heineman, Thomas

Senior Officer of Issuer

Officer
15,000 +11.3%
1.27
US$19,050 		15,000 +11.3% 1.27 US$19,050
2025-07-18 2025-07-17 B Purchase
Hagerman, Allison

Senior Officer of Issuer

Officer
4,600 +7.3%
1.71
CA$7,866 		4,600 +7.3% 1.71 CA$7,866
2025-07-17 2025-07-16 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
50,400
1.19
US$60,062 		50,400 1.19 US$60,062
2025-07-17 2025-07-15 B Purchase
Look, Kirk

Senior Officer of Issuer

Officer
12,800 +9.3%
1.17
US$14,976 		12,800 +9.3% 1.17 US$14,976
2025-07-17 2025-07-15 B Purchase
Aromando, Andrew P.

Senior Officer of Issuer

Officer
25,500
1.19
US$30,238 		25,500 1.19 US$30,238
Explore more

More insider trading research around Oncolytics Biotech Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America